Consortium of Multiple Sclerosis Centers 2015 Annual Meeting
The revised guidelines stress the use of high-quality imaging and consistency in images taken.
People with MS who have comorbidities may be more likely to experience disruptive pain.
Another study suggests that a telehealth system could help objectively monitor dose adherence.
Rates were similar, but gender and age-specific differences emerged.
Insurance coverage can be the determining factor on whether a patient receives DMT or not.
A team to address both the physical and emotional outcomes of MS relapse is essential to high quality care.
A combination of physical, occupational, hand, speech, cognitive, and behavioral therapy improves outcomes.
Sign Up for Free e-newsletters
Check out what's trending
Neurology Advisor Articles
- OCD in Duchenne Muscular Dystrophy Features Distinct Phenotype, Associated Symptoms
- History of Migraine Associated With Higher Risk for Cochlear Disorders
- Vagus Nerve Stimulation in Pediatric Epilepsy: Weighing the Risks and Benefits
- A Model for Predicting Quality of Life Improvements After Deep Brain Stimulation
- Identifying Intracranial Hypertension in Children: Added Challenges
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- Insurance Status Tied to Higher Self-Perceived Poor/Fair Health
- Early Treatment Failure More Likely With Carbamazepine vs Lamotrigine in Epilepsy
- Rasagiline Plus Riluzole is Safe, May Improve Survival in ALS
- Concurrent Non-Motor Functions Strongly Associated With Parkinson Disease
- Feeling Young May Be Reflected in Brain Structure